Companion Diagnostics Market: Global Innovation and Advancement

The global Companion Diagnostics Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.

Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the companion diagnostics market include Abbott Laboratories Molecular, Inc., Agilent, ARUP Laboratories, Inc., BioMerieux SA, Danaher Corporation.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Companion Diagnostics Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/companion-diagnostic-market/download-sampleMarket DynamicsCompanion diagnostics are a crucial part of personalized medicine and will likely continue to rapidly increase in the number of disease areas.

Oncology is a segment of major focus and will remain at the forefront for the foreseeable future.

Companion diagnostic play a major role in oncology research and has revolutionized the treatment of cancer by allowing doctors to adjust drug therapy to achieve better clinical results.

Market HighlightsGlobal Companion Diagnostics Market is expected to register a CAGR of 20.29% during the forecast period, with a market value of USD 8,081.50 Million by 2027.

The market, based on products & services, has been bifurcated into assays, kits, & reagents, and software & services.

On the basis of technology, the market has been bifurcated into polymerase chain reaction (PCR), next-generation sequencing (NGS), in-situ hybridization, immunohistochemistry, and other technologies.The market based on indication has been segmented into cancer, neurological diseases, infectious diseases, cardiovascular diseases, and others.

Based on end user, the companion diagnostics market has been segregated into pharmaceutical & biopharmaceutical companies, laboratories, contract research organizations, and others.Regional AnalysisThe companion diagnostics market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is likely to dominate the global companion diagnostics market.

This can be attributed to the increasing demand for personalized medicine and the rising prevalence of various chronic diseases such as cancer, neurological disorders, and cardiac diseases among others.

According to the American Cancer Society, 1.8 million new cancer cases will be diagnosed in 2020 in the US.

The Global Companion Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.

The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.

The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on technology, application and end-user.

These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.

The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Companion Diagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/16699-companion-diagnostics-market-reportThe report also covers the complete competitive landscape of the global Companion Diagnostics market with company profiles of key players such as:Abbott Laboratories, Inc.Agilent Technologies, Inc.BiomérieuxBiogenex LaboratoriesDanaher CorporationGe HealthcareMyriad Genetics, Inc.Qiagen N.V.Roche DiagnosticsThermo Fisher Scientific, Inc.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Technology:Polymerase Chain Reaction Test (PCR)Immunohistochemistry Test (IHC)In-Situ Hybridization Test (ISH)Others (Next-generation Sequencing, Multiplex Assay Test, Monoclonal Antibodies Test, and Cellular Immune Testing)By Applications:Breast CancerNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Melanoma CancerGastric CancerOthers (Neurology, Prostate Cancer, Ovarian Cancer, and Infectious Diseases)By End-User:Pharmaceutical CompaniesReference LaboratoriesOthers (Physicians, Hospitals, Academic Medical Centers, and Contract Research Organizations)By Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Rest of the World (RoW)Download Free Sample Report of Global Companion Diagnostics Market @ https://www.decisiondatabases.com/contact/download-sample-16699The Global Companion Diagnostics Market has been exhibited in detail in the following chapters –Chapter 1 Companion Diagnostics Market PrefaceChapter 2 Executive SummaryChapter 3 Companion Diagnostics Industry AnalysisChapter 4 Companion Diagnostics Market Value Chain AnalysisChapter 5 Companion Diagnostics Market Analysis By TechnologyChapter 6 Companion Diagnostics Market Analysis By ApplicationsChapter 7 Companion Diagnostics Market Analysis By End-UserChapter 8 Companion Diagnostics Market Analysis By GeographyChapter 9 Competitive Landscape Of Companion Diagnostics CompaniesChapter 10 Company Profiles Of Companion Diagnostics IndustryPurchase the complete Global Companion Diagnostics Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16699Other Reports by DecisionDatabases.com:Global Neurodiagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Malaria Diagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Influenza Diagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.

The Global Companion Diagnostics Market size was valued at USD 1.96 billion in 2019 and is predicted to reach USD 9.02 billion by 2030, with a CAGR of 14.8% from 2020-2030.The Global Companion Diagnostics Market report factual examinations gives showcase statistical data points to comprehend the present and future development of the worldwide Companion Diagnostics Market.

Profound inquiries about and investigations were finished during the planning of the report.

This upgrades the visual portrayal and furthermore helps in understanding the certainties much better.

The report centers around worldwide real driving Companion Diagnostics Market players giving data, for example, organization profiles, item picture and determination, limit, creation, value, cost, income and contact data.

Upstream crude materials and gear and downstream interest examination is likewise completed.Inquire for discount offer at:-https://www.nextmsc.com/companion-diagnostics-market/inquire-before-buyingStudy on Table of Contents:Companion Diagnostics Market Overview, Scope, Status and Prospect (2015-2020) covering COVID-19 Pandemic.Global Companion Diagnostics Market Competition by ManufacturersGlobal Companion Diagnostics Supply (Production), Consumption, Export, Import by Region (2015-2020)Companion Diagnostics Manufacturing Cost Analysis, Industrial Chain, Sourcing Strategy and Downstream Buyers, Marketing Strategy Analysis, Distributors/TradersGlobal Companion Diagnostics Market Effect Factors Analysis and Forecast (2020-2030)Research Findings and Conclusion Appendix – Methodology/Research Approach, Market Size Estimation, Data Source, Secondary Sources, Primary Sources, and Disclaimer.About Next Move Strategy Consulting:Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share.

Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade.

This report aims to provide detailed insights into the global companion diagnostic market.

It provides valuable information on the type, procedure, application, and region in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155571681 Key Factors Driving Market Growth: The growth of the Companion Diagnostics Market is tied primarily to the advantages of companion diagnostics, the growing need for targeted therapy, the increasing importance of personalized medicine, the rising global incidence of cancer, and the ever-increasing application areas of companion diagnostics.

The increasing demand for next-generation sequencing, the growing significance of companion diagnostics in drug development, and the rising number of clinical trials are also expected to present growth opportunities for players in the market, which also expected to support market growth in the coming years.

Assays, kits, & reagents segment to account for the largest share of the Companion Diagnostics Market, by product & service The assays, kits, & reagents segment is expected to account for the largest share of the market in 2019.

This is attributed to the availability of a wide range of assays, kits, & reagents in companion diagnostics, increasing the use of assays & kits in different therapeutic areas, and the growing demand for assays & kits in basic research and commercial applications which drives the growth of this segment.

A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain diseases could be benefitted by a particular drug through the biomarker assessment.

The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.The global companion diagnostics market is expected to reach USD 6.51 billion by 2022 from USD 2.17 billion in 2016, at a CAGR of 20.1%.Market Dynamics+ Drivers+ Improvements in regulatory guidelines+ Growing need for targeted therapies+ Rising cancer incidence worldwide+ Increasing collaborations and partnerships for companion diagnostics test developmentIncreasing collaborations and partnerships for companion diagnostics test developmentOwing to the advantages of companion diagnostics in drug approval processes, an increasing number of pharmaceutical companies have entered into partnerships and collaborations with different companion diagnostic companies to develop and commercialize companion diagnostics tests for their drugs.

For instance, in 2016, Agilent Technologies, Inc. and Applied Spectral Imaging (ASI) entered into a marketing agreement.

ASI's most advanced GenASIs imaging platforms and Agilent's fluorescence in situ hybridization (FISH) products and solutions will be marketed by them.

Simalarly in 2016, QIAGEN collaborated with Array BioPharma to develop and commercialize a companion diagnostic test.

The test will be developed for Array BioPharma's binimetinib, an MEK inhibitior.Download Free PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155571681Software and ServicesCompanion diagnostics software is used to streamline the research and analysis of diagnostic results.